Skip to main content
. 2022 Aug 9;9:945591. doi: 10.3389/fnut.2022.945591

Table 4.

Association between NOVA score and CVD risk factors, anthropometric measurements, body composition, biochemical variables, and inflammatory factors in obese and overweight women (n = 391).

Variables NOVA score P-value P-value*
β (SE) CI (95%)
Body composition
FFM (Kg) Crude −0.001 (0.002) −0.005, 0.003 0.682 -
Model 1 −0.004 (0.004) −0.011, 0.003 - 0.278
Model 2 −0.004 (0.004) 0.001, 0.001 - 0.056
FFMI Crude −0.004 (0.003) −0.009, 0.001 0.115 -
Model 1 −0.001 (0.001) −0.003, 0.001 - 0.201
Model 2 −0.001 (0.001) −0.003, 0.001 - 0.376
FMI Crude −0.004 (0.001) −0.014, 0.006 0.427 -
Model 1 0.001 (0.002) −0.005, 0.004 - 0.878
Model 2 −5.286 (0.002) −0.004, 0.004 - 0.981
BF (%) Crude 0.003 (0.002) −0.001, 0.007 0.148 -
Model 1 0.001 (0.004) −0.006, 0.008 - 0.768
Model 2 0.001 (0.004) −0.006, 0.008 - 0.768
BFM (Kg) Crude 0.006 (0.003) −0.001, 0.013 0.084 -
Model 1 −0.002 (0.006) −0.013, 0.009 - 0.719
Model 2 −0.002 (0.006) −0.014, 0.009 0.658
TF (kg) Crude 0.002 (0.001) 0.001, 0.005 0.097 -
Model 1 −0.001 (0.002) −0.005, 0.004 - 0.812
Model 2 −0.001 (0.002) −0.006, 0.004 - 0.709
TF (%) Crude 0.035 (0.028) −0.020, 0.089 0.213 -
Model 1 0.001 (0.044) −0.086, 0.088 - 0.988
Model 2 −0.005 (0.045) −0.094, 0.083 - 0.904
VFA (CM2) Crude 0.028 (0.037) −0.044, 0.100 0.442 -
Model 1 −0.005 (0.082) −0.168, 0.157 - 0.951
Model 2 −0.007 (0.085) −0.174, 0.159 - 0.930
VFL Crude 0.002 (0.005) −0.007, 0.012 0.647 -
Model 1 0.005 (0.011) −0.017, 0.028 - 0.651
Model 2 0.006 (0.012) −0.017, 0.029 - 0.076
Biochemical variables
Insulin (mIU/ml) Crude −6.160 (0.001) 0.001, 0.001 0.617 -
Model 1 0.001 (0.001) −0.001, 0.000 - 0.230
Model 2 0.001 (0.001) 0.001, 0.001 - 0.273
HOMA_IR Crude 0.001 (0.001) −0.0002, 0.001 0.671 -
Model 1 −2.096 (0.001) −0.002, 0.002 - 0.981
Model 2 0.001 (0.001) 0.001, 0.033 - 0.055
QUICKI (mg/lit) Crude −1.731 (0.001) 0.001, 0.001 0.205 -
Model 1 −4.306 (0.001) −0.001, 0.001 - 0.720
Model 2 −3.775 (0.001) 0.001, 0.001 - 0.042
hs-CRP (mg/l) Crude 0.001 (0.003) −0.005, 0.005 0.962 -
Model 1 0.001 (0.003) −0.006, 0.007 - 0.875
Model 2 0.001 (0.003) −0.006, 0.007 - 0.916
FBG (mg/dL) Crude −0.004 (0.005) −0.014, 0.006 0.427 -
Model 1 −0.004 (0.006) −0.017, 0.009 - 0.506
Model 2 −0.006 (0.007) −0.020, 0.007 - 0.335
SBP (mmHg) Crude −0.012 (0.007) −0.027, 0.002 0.102 -
Model 1 −0.015 (0.008) −0.032, 0.002 - 0.032
Model 2 0.017 (0.008) −0.001, 0.020 - 0.148
DBP (mmHg) Crude −0.008 (0.005) −0.018, 0.002 0.134 -
Model 1 −0.004 (0.086) −0.016, 0.008 - 0.503
Model 2 −0.007 (0.006) −0.019, 0.005 - 0.236
TC (mg/dL) Crude 0.003 (0.019) −0.036, 0.041 0.893 -
Model 1 0.012 (0.022) −0.032, 0.055 - 0.598
Model 2 0.020 (0.022) −0.024, 0.064 - 0.073
TG (mg/dL) Crude 0.003 (0.032) −0.060, 0.067 0.916 -
Model 1 0.031 (0.042) −0.052, 0.115 - 0.456
Model 2 0.041 (0.043) −0.044, 0.126 - 0.344
HDL
(mg/dL)
Crude −0.005 (0.006) −0.016, 0.006 0.391 -
Model 1 −0.004 (0.007) −0.017, 0.010 - 0.588
Model 2 −0.002 (0.007) −0.016, 0.011 - 0.720
LDL
(mg/dL)
Crude −0.010 (0.013) −0.036, 0.015 0.433 -
Model 1 −6.043 (0.015) −0.030, 0.030 - 0.997
Model 2 0.007 (0.016) −0.024, 0.038 - 0.662
GOT (mg/dL) Crude −0.004 (0.004) −0.012, 0.0003 0.274 -
Model 1 −0.007 (0.005) −0.017, 0.003 - 0.167
Model 2 −0.006 (0.005) −0.017, 0.004 - 0.245
GPT (mg/dL) Crude −0.006 (0.007) −0.020, 0.008 0.391 -
Model 1 −0.016 (0.009) −0.034, 0.003 - 0.097
Model 2 −0.015 (0.010) −0.034, 0.004 - 0.117
PAI-1 (mg/dL) Crude −0.019 (0.022) −0.063, 0.025 0.401 -
Model 1 −0.012 (0.033) −0.077, 0.053 - 0.705
Model 2 −0.005 (0.033) −0.071, 0.061 - 0.883
MCP1 (mg/dL) Crude −0.047 (0.052) −0. 15, 0.055 0.363 -
Model 1 −0.041 (0.072) −0.184, 0.102 - 0.570
Model 2 −0.039 (0.073) −0.184, 0.107 -
TGF (mg/dL) Crude 0.034 (0.036) −0.038, 0.106 0.106
Model 1 0.092 (0.038) 0.016, 0.167 - 0.018
Model 2 0.101 (0.040) 0.023, 0.180 - 0.012
IL-1 β (mg/dL) Crude 0.001 (0.001) −0.001, 0.003 0.250 -
Model 1 0.001 (0.001) −0.002, 0.003 - 0.596
Model2 0.001 (0.001) −0.001, 0.003 - 0.060
AIP (mg/dL) Crude 2.472 (0.001) 0.001, 0.01 0.853 -
Model 1 0.001 (0.001) 0.001, 0.001 - 0.482
Model2 0.001 (0.001) −0.001, 0.011 - 0.072
CRI-I Crude 0.001 (0.001) −0.001, 0.002 0.476 -
Model 1 0.001 (0.001) −0.001, 0.002 - 0.277
Model2 0.001 (0.001) −0.001, 0.002 - 0.064
CRI-II Crude −3.679 (0.001) −0.001, 0.001 0.907 -
Model 1 0.001 (0.001) −0.001, 0.001 - 0.574
Model2 0.001 (0.001) 0.001, 0.001 - 0.431
AC Crude 0.001 (0.001) −0.001, 0.002 0.476 -
Model 1 0.001 (0.001) −0.001, 0.002 - 0.277
Model2 0.011 (0.001) 0.001, 0.032 - 0.034
CHOlIndex Crude −0.005 (0.012) −0.029, 0.019 0.688 -
Model 1 0.004 (0.015) −0.026, 0.033 - 0.811
Model2 0.009 (0.015) −0.021, 0.040 - 0.547
TyG Crude −6.963 (0.001) −0.001, 0.001 0.794 -
Model 1 0.001 (0.001) 0.001, 0.001 - 0.610
Model2 0.001 (0.001) 0.001, 0.001 - 0.501
TyG-BMI Crude 0.010 (0.023) −0.035, 0.055 0.648 -
Model 1 −0.012 (0.028) −0.67, 0.044 - 0.685
Model 2 −0.003 (0.029) −0.060, 0.054 - 0.917
TyG-WC Crude 0.061 (0.105) −0.146, 0.267 0.563 -
Model 1 −0.056 (0.177) −0.408, 0.296 - 0.752
Model 2 0.048 (0.188) −0.324, 0.421 - 0.797

AC, atherogenic coefficient; BFM, body fat mass; BF, body fat; FFM, fat-free mass; FMI, fat mass index; FFMI, fat-free mass index; IL-1β, interleukin-1 beta; MCP-1, monocyte chemoattractant protein-1; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBS, fasting blood sugar; TG, triglyceride; HDL, high-density lipoprotein; LDL, low-density lipoprotein; GPT, glutamic-pyruvic transaminase; GOT, glutamic-oxaloacetic transaminase; PAI-1, plasminogen activator inhibitor- 1, SD standard deviation; hs-CRP, high sensitive- C reactive protein; TF, trunk Fat; VFA, visceral fat area; VFL, visceral fat level; TC, total cholesterol; AIP, Atherogenic index of plasma; TyG, Triglyceride-glucose; TGF, Transforming growth factor; CRI: Cardiac risk index.

Model 1: Adjusted for age, BMI, physical activity, total energy intake, supplements intake, and job status (BMI considered as a collinear variable).

Model 2: In addition controlled for the role of vegetables and legumes.

*A P-value obtained from adjustment. All of the p-values obtained from the analysis of the linear regression.

A P < 0.05 was considered significant and p-values equal to 0.05, 0.06, and 0.07 were considered marginally significant.